Showing results (291-300 of 449) with videos related to
Sort By:
Pageof 45
Journal of the National Cancer Institute|January 30, 2016
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsPaul D P Pharoah, Honglin Song, Ed Dicks, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2016
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian CancerYing Chen, Sandra Catalina Camacho, Thomas R Silvers, et al.Cancer Research|November 30, 2018
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility LocusMelissa A Buckley, Nicholas T Woods, Jonathan P Tyrer, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.European Journal of Human Genetics : EJHG|February 12, 2025
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.International Journal of Cancer|July 16, 2016
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancerAlice W Lee, Ashley Bomkamp, Elisa V Bandera, et al.Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.Fertility and Sterility|August 20, 2010
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effortAimee M Near, Anna H Wu, Claire Templeman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.Pageof 45